Elanco Animal Health (NYSE:ELAN) and Super Nova Resources (OTCMKTS:SNRR) Critical Analysis

Super Nova Resources (OTCMKTS:SNRR) and Elanco Animal Health (NYSE:ELAN) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, valuation, institutional ownership, risk, earnings, dividends and profitability.

Institutional & Insider Ownership

97.5% of Elanco Animal Health shares are held by institutional investors. 17.6% of Super Nova Resources shares are held by company insiders. Comparatively, 0.9% of Elanco Animal Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Volatility and Risk

Super Nova Resources has a beta of 0.49, indicating that its stock price is 51% less volatile than the S&P 500. Comparatively, Elanco Animal Health has a beta of 1.71, indicating that its stock price is 71% more volatile than the S&P 500.

Analyst Ratings

This is a summary of current ratings and recommmendations for Super Nova Resources and Elanco Animal Health, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Super Nova Resources	0	0	0	0	0.00
Elanco Animal Health	0	3	6	2	2.91

Elanco Animal Health has a consensus price target of $20.29, indicating a potential downside of 5.02%. Given Elanco Animal Health’s stronger consensus rating and higher possible upside, analysts plainly believe Elanco Animal Health is more favorable than Super Nova Resources.

Profitability

This table compares Super Nova Resources and Elanco Animal Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Super Nova Resources	N/A	N/A	N/A
Elanco Animal Health	9.68%	7.04%	3.45%

Valuation & Earnings

This table compares Super Nova Resources and Elanco Animal Health”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Super Nova Resources	N/A	N/A	N/A	N/A	N/A
Elanco Animal Health	$4.48 billion	2.37	$338.00 million	$0.06	355.98

Elanco Animal Health has higher revenue and earnings than Super Nova Resources.

Summary

Elanco Animal Health beats Super Nova Resources on 10 of the 11 factors compared between the two stocks.

About Super Nova Resources

Super Nova Resources, Inc. provides employment screening and talent management software as a service. The company's employment screening services include assessment tests, background checks, drug and alcohol testing, and Form I-9 compliance. Its integrated talent management software suite consists of three modules for applicant tracking, onboarding, and performance management. The company's clients principally operate in markets, such as healthcare, staffing, transportation-logistics, and retail-hospitality. It delivers its services to approximately 1,000 clients in the United States. Super Nova Resources, through its division, Greenlink Interactive, also provides sales and marketing services to partner companies for a range of industries, venues, and customer types via its interactive technologies and distribution channels. The company develops business models for various sectors, products, and services, including home improvement products, wellness, apparel, real estate, housing, and gifts. It utilizes specialized marketing techniques in conjunction with proprietary Greenlink Interactive Video Assistance, Always-On, and Point-of-Decision Systems to market and sell products and services. In addition, Super Nova Resources has a joint venture agreement with Early Detect, Inc. to develop Live Interactive Point-of-Decision Systems to be deployed in retail locations. The company was formerly known as Navicus, Inc. and changed its name to Super Nova Resources, Inc. in November 2008. Super Nova Resources, Inc. was incorporated in 1965 and is based in Corona, California.

About Elanco Animal Health

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.